Sarepta Therapeutics (NASDAQ:SRPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Recs

0
Player Avatar Newt805 (68.93) Submitted: 10/4/2012 4:27:06 PM : Outperform Start Price: $4.14 SRPT Score: +770.54

Is this another NVR?

Report this Post 1 Reply
Member Avatar Mikimikkers (99.79) Submitted: 10/5/2012 5:01:03 PM
Recs: 1

Great call!

Report this Post

Featured Broker Partners


Advertisement